NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Global investors are piling into Latin American stocks at the fastest clip in a decade, sending markets across the region to multi-year highs.Read More